Bio-Path Holdings, Inc.: 10-K filed 2014-03-31

Name: Bio-Path Holdings, Inc.: 10-K filed 2014-03-31
Creator: Bio-Path Holdings, Inc.

What Bio-Path Holdings, Inc. reported in its annual report filed 2014-03-31 (fiscal FY 2013): 26 published measures, 92 facts as tagged in accession 0001144204-14-019417.

This filing

Form: 10-K (annual report)
Filed: 2014-03-31
Fiscal period: fiscal FY 2013
Accession: 0001144204-14-019417 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Bio-Path Holdings, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2013-12-31	5,078,831	USD
At 2012-12-31	2,343,764	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2013-12-31	294,898	USD
At 2012-12-31	329,244	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2013-12-31	4,783,933	USD
At 2012-12-31	2,014,520	USD
At 2011-12-31	2,914,974	USD
At 2010-12-31	2,861,746	USD
At 2009-12-31	3,416,763	USD
At 2009-09-30	3,107,344	USD
At 2009-06-30	3,371,750	USD
At 2009-03-31	3,607,984	USD
At 2008-12-31	4,060,020	USD
At 2008-09-30	4,538,099	USD
At 2008-06-30	4,759,264	USD
At 2008-03-31	5,003,497	USD
At 2007-12-31	3,743,235	USD
At 2007-09-30	1,592,775	USD
At 2007-06-30	-76,477	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2013-01-01 to 2013-12-31	-3,266,013	USD	365
2007-05-10 to 2013-12-31	-15,397,296	USD	2428
2012-01-01 to 2012-12-31	-2,582,537	USD	366
2011-01-01 to 2011-12-31	-2,363,344	USD	365
2010-01-01 to 2010-12-31	-2,081,500	USD	365
2009-10-01 to 2009-12-31	-432,795	USD	92
2009-07-01 to 2009-09-30	-407,200	USD	92
2009-04-01 to 2009-06-30	-533,049	USD	91
2009-01-01 to 2009-03-31	-596,694	USD	90
2008-10-01 to 2008-12-31	-1,891,256	USD	92
2008-07-01 to 2008-09-30	-239,049	USD	92
2008-04-01 to 2008-06-30	-496,256	USD	91
2008-01-01 to 2008-03-31	-226,206	USD	91
2007-10-01 to 2007-12-31	-143,201	USD	92
2007-07-01 to 2007-09-30	-81,986	USD	92
2007-05-07 to 2007-06-30	-56,210	USD	55

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2013-01-01 to 2013-12-31	-2,313,160	USD	365
2007-05-10 to 2013-12-31	-9,353,789	USD	2428
2012-01-01 to 2012-12-31	-1,993,404	USD	366

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Unit	Days
2013-01-01 to 2013-12-31	USD	365
2007-05-10 to 2013-12-31	USD	2428
2012-01-01 to 2012-12-31	USD	366

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2013-01-01 to 2013-12-31	5,330,946	USD	365
2007-05-10 to 2013-12-31	13,790,331	USD	2428
2012-01-01 to 2012-12-31	1,600,198	USD	366

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2013-01-01 to 2013-12-31	0	USD	365
2007-05-10 to 2013-12-31	-884,710	USD	2428
2012-01-01 to 2012-12-31	-25,000	USD	366

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Unit	Days
2013-01-01 to 2013-12-31	USD	365
2007-05-10 to 2013-12-31	USD	2428
2012-01-01 to 2012-12-31	USD	366

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2013-01-01 to 2013-12-31	704,480	USD	365
2007-05-10 to 2013-12-31	3,718,233	USD	2428
2012-01-01 to 2012-12-31	63,385	USD	366

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2013-01-01 to 2013-12-31	-3,269,240	USD	365
2007-05-10 to 2013-12-31	-15,717,919	USD	2428
2012-01-01 to 2012-12-31	-2,582,679	USD	366

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2013-12-31	3,667,313	USD
At 2012-12-31	771,621	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2013-12-31	294,898	USD
At 2012-12-31	329,244	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2013-12-31	76,109	USD
At 2012-12-31	57,000	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2013-01-01 to 2013-12-31	3,269,240	USD	365
2007-05-10 to 2013-12-31	15,717,919	USD	2428
2012-01-01 to 2012-12-31	2,582,679	USD	366

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2013-01-01 to 2013-12-31	1,518,885	USD	365
2007-05-10 to 2013-12-31	5,844,481	USD	2428
2012-01-01 to 2012-12-31	1,132,712	USD	366

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2013-12-31	84,237,872	shares
At 2012-12-31	62,219,050	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2013-12-31	20,096,991	USD
At 2012-12-31	13,321,075	USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

Period	Value	Unit	Days
At 2013-12-31	1,411,518	USD
At 2012-12-31	1,572,143	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2013-12-31	66,739	USD
At 2012-12-31	137,662	USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

Period	Value	Unit	Days
At 2013-12-31	0	USD
At 2012-12-31	0	USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2013-01-01 to 2013-12-31	1,634,650	USD	365
2007-05-10 to 2013-12-31	8,694,113	USD	2428
2012-01-01 to 2012-12-31	986,097	USD	366

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

Period	Value	Unit	Days
2013-01-01 to 2013-12-31	1,088,856	USD	365
2012-01-01 to 2012-12-31	928,231	USD	366

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2013-01-01 to 2013-12-31	3,227	USD	365
2007-05-10 to 2013-12-31	320,623	USD	2428
2012-01-01 to 2012-12-31	142	USD	366

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2013-01-01 to 2013-12-31	5,330,946	USD	365
2007-05-10 to 2013-12-31	13,370,331	USD	2428
2012-01-01 to 2012-12-31	1,600,198	USD	366

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2013-01-01 to 2013-12-31	-143,636	USD	365
2007-05-10 to 2013-12-31	51,364	USD	2428
2012-01-01 to 2012-12-31	42,000	USD	366

Inspect the source

Entity: Bio-Path Holdings, Inc. / CIK 0001133818
Captured: 2026-09-20T07:41:23.212Z
SEC response SHA-256: ba1a5b94a703d7df40927e88576df9dbcb07b38680ce9a942065f8bd6fea9eee

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001133818.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))